Interim Report Third Quarter 2023
STENOCARE A/SNASDAQ FIRST NORTH GROWTH MARKET, DENMARKTICKER: STENOSTENOCARE A/S (“STENOCARE”) today announces its results for the period 01.01.2023 – 30.09.2023. The report, which has not been reviewed by the Company’s auditors, is attached to this release and is also available on https://stenocare.com/investor-relations/ Thomas Skovlund Schnegelsberg, CEO of STENOCARE, comments:” Stenocare has successfully managed to grow sales to patients during the first three quarters of 2023. We have proven our strategic assets and are very optimistic about the road ahead.” (KDKK)